Stay updated on Timing of Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the Timing of Pembrolizumab in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new study record version (689, dated 2026-07-02) was added, updating the Study Status and the Contacts/Locations sections and referencing Revision: v3.6.3; the prior version on 2026-06-17 (Revision: v3.6.2) was removed.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision: v3.6.2 was added to the history and Revision: v3.6.0 was removed.SummaryDifference0.0%

- Check27 days agoChange DetectedVersion 686 and 687 were added to the study history on 2026-06-12 and 2026-06-17, updating the Study Status and Contacts/Locations; the 2026-05-29 entry was deleted.SummaryDifference0.1%

- Check35 days agoChange DetectedNew entry states No longer looking for participants and the record shows Revision: v3.6.0. The prior Revision: v3.5.5 entry was removed.SummaryDifference0.0%

- Check42 days agoChange DetectedA new history entry for revision v3.5.5 dated 2026-05-29 was added, including Contacts/Locations and Study Status, and the previous entry for 2026-05-26 (Revision: v3.5.4) was removed.SummaryDifference0.0%

- Check50 days agoChange DetectedNew entries were added to the history under Study Status for 2026-05-26 and a related 2026-05-22 entry with the value 684, and an entry dated 2026-05-13 was removed.SummaryDifference0.0%

Stay in the know with updates to Timing of Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.